IL17A and myeloid sarcoma: In the context of experimental autoimmune encephalomyelitis (EAE), the most commonly used experimental model for human inflammatory demyelinating disease, including MS [99], IL-23 stimulates myelin-reactive T cells to produce both IFN-γ and IL-17, contributing to the generation of encephalitogenic Th17 cells [100].